{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:58:57Z","timestamp":1788872337354,"version":"build-2803163510"},"reference-count":160,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014498","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T06:54:21Z","timestamp":1688972061000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy"],"prefix":"10.1002","volume":"2023","author":[{"given":"Anouk","family":"Pels","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessel","family":"Ganzevoort","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C","family":"Kenny","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N","family":"Baker","sequence":"additional","affiliation":[{"name":"College of Life Sciences; University of Leicester; Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; King's College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; Capital Region, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag T","family":"Kariya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleid G","family":"Leemhuis","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Emma Children\u2019s Hospital; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M","family":"Groom","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N","family":"Sharp","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A","family":"Magee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; King's College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus C","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Monash University; Clayton Australia"},{"name":"Aberdeen Centre for Women's Health Research, Institute of Applied Health Sciences, School of Medicine, Medial Sciences and Nutrition; University of Aberdeen; Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris T","family":"Papageorghiou","sequence":"additional","affiliation":[{"name":"Fetal Medicine Unit; St George's, University of London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/gye.16.3.187.192","article-title":"Maternal nitric oxide supplementation increases adrenomedullin concentrations in growth retarded fetuses","volume":"16","author":"Di Iorio","year":"2002","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD014498-BIB0002|cit2","unstructured":"STRIDER (NZAus): a randomised placebo-controlled trial of a new therapy (sildenafil) to help growth in severely growth restricted fetuses at very early gestations Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12612000584831"},{"issue":"8","key":"10.1002\/14651858.CD014498-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/1471-0528.15658","article-title":"STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction","volume":"126","author":"Groom","year":"2019","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014498-BIB0004|cit4","first-page":"23","article-title":"Sildenafil for severe, early-onset intrauterine growth restriction and neonatal cardiovascular function: a substudy of the strider NZAus randomised placebo-controlled trial","volume":"55","author":"Harris","year":"2019","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD014498-BIB0005|cit5","first-page":"100009","article-title":"Neonatal cardiovascular function after antenatal sildenafil for severe, early-onset intrauterine growth restriction: a substudy of the STRIDER NZAus randomized placebo-controlled trial","volume":"1","author":"Harris","year":"2019","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/j.ajog.2018.11.395","article-title":"374: tadalafil treatment for fetus with early onset growth restriction (tadafer) a multicenter phase ii trial","volume":"220","author":"Maki","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/jcm8060856","article-title":"Safety evaluation of tadalafil treatment for fetuses with early-onset growth restriction (TADAFER): results from the phase II trial","volume":"8","author":"Maki","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD014498-BIB0008|cit8","unstructured":"Sildenafil for early severe fetal growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2012-004112-63-NL"},{"key":"10.1002\/14651858.CD014498-BIB0009|cit9","unstructured":"The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction) Https:\/\/clinicaltrials.gov\/show\/nct02277132"},{"key":"10.1002\/14651858.CD014498-BIB0010|cit10","unstructured":"Does Sildenafil improve the neonatal prognosis in severe early onset growth restriction? Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=NTR4751"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD014498-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S682","DOI":"10.1016\/j.ajog.2018.12.005","article-title":"LB 2: maternal sildenafil for severe early-onset fetal growth restriction: the Dutch multicentre placebo-controlled double-blind STRIDER-trial","volume":"220","author":"Pels","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"e205323","DOI":"10.1001\/jamanetworkopen.2020.5323","article-title":"Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial","volume":"3","author":"Pels","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13063-018-3136-z","article-title":"Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy in Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction","volume":"20","author":"Pels","year":"2019","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12884-017-1594-z","article-title":"STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials","volume":"17","author":"Pels","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.1002\/14651858.CD014498-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2018.12.041","article-title":"Neurodevelopmental outcomes at five years after early-onset fetal growth restriction: analyses in a dutch subgroup participating in a european management trial","volume":"234","author":"Pels","year":"2019","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00431-021-04355-x","article-title":"Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study","volume":"181","author":"Pels","year":"2022","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD014498-BIB0017|cit17","unstructured":"STRIDER - Sildenafil therapy for treatment of intrauterine growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2013-005398-32-GB"},{"key":"10.1002\/14651858.CD014498-BIB0018|cit18","unstructured":"Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN39133303"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/uog.20851","article-title":"Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial","volume":"55","author":"Khalil","year":"2019","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD014498-BIB0020|cit20","first-page":"25","article-title":"Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial","volume":"125","author":"Khalil","year":"2018","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child and Adolescent Health"},{"key":"10.1002\/14651858.CD014498-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejogrb.2019.08.007","article-title":"A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction","volume":"241","author":"Sharp","year":"2019","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0023|cit23","first-page":"90","article-title":"Correction to Lancet Child Adolesc Health 2018; 2: 93-102 (The Lancet Child and Adolescent Health (2018) 2(2) (93-102) (S2352464217301736) (10.1016\/S2352-4642(17)30173-6))","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child and Adolescent Health"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2352-4642(19)30020-3","article-title":"Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction","volume":"3","author":"Sharp","year":"2019","journal-title":"Lancet Child and Adolescent Health"},{"key":"10.1002\/14651858.CD014498-BIB0025|cit25","unstructured":"Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction https:\/\/www.isrctn.com\/ISRCTN39133303"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.15673","article-title":"Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices","volume":"48","author":"Goncalves","year":"2016","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014498-BIB0027|cit27","unstructured":"Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (STRIDERCan) https:\/\/clinicaltrials.gov\/ct2\/show\/"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13104-022-06107-y","article-title":"Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations","volume":"15","author":"Dadelszen","year":"2022","journal-title":"BMC Research Notes"},{"key":"10.1002\/14651858.CD014498-BIB0029|cit29","unstructured":"L-arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double bind controlled trial (L arginine in IUGR) Https:\/\/clinicaltrials.gov\/show\/NCT00549575"},{"key":"10.1002\/14651858.CD014498-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/uog.4150","article-title":"Treatment of severe vascular fetal intrauterine growth restriction with L-arginine: a multicenter prospective double-blind randomized placebo-controlled study","volume":"30","author":"Winer","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clnu.2009.03.007","article-title":"L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-blind controlled trial","volume":"28","author":"Winer","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10641955.2018.1446977","article-title":"Changes in endothelial function, arterial stiffness and blood pressure in pregnant women after consumption of high-flavanol and high-theobromine chocolate: a double blind randomized clinical trial","volume":"37","author":"Babar","year":"2018","journal-title":"Hypertension in Pregnancy"},{"issue":"9","key":"10.1002\/14651858.CD014498-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1515\/jpm-2017-0238","article-title":"Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial","volume":"46","author":"Bowkalow","year":"2018","journal-title":"Journal of Perinatal Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD014498-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ajog.2015.10.056","article-title":"High-flavanol chocolate to improve placental function and to decrease the risk of preeclampsia: a double blind randomized clinical trial","volume":"214","author":"Bujold","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10641955.2015.1137586","article-title":"Efficacy of l-arginine for preventing preeclampsia in high-risk pregnancies: a double-blind, randomized, clinical trial","volume":"35","author":"Pulido","year":"2016","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD014498-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Decano MB Cabrera LT The effects of transdermal nitroglycerin (nitrol patch) on the uterine and umbilical artery blood flow in preeclampsia: a randomized double blind placebo controlled study [abstract] XVI FIGO World Congress of Obstetrics & Gynecology; 2000 Sept 3-8; Washington DC, USA (Book 1) 2000 26","DOI":"10.1016\/S0020-7292(00)82035-4"},{"key":"10.1002\/14651858.CD014498-BIB0037|cit37","unstructured":"Pentaeritrithyl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=DRKS00011374"},{"key":"10.1002\/14651858.CD014498-BIB0038|cit38","first-page":"S22","article-title":"A prospective randomised controlled trial of nitric oxide donors in at risk pregnancy [abstract]","volume":"21 Suppl 1","author":"El-Hamedi","year":"2001","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0039|cit39","first-page":"31","article-title":"Effect of sildenafil citrate on uteroplacental perfusion Doppler indices in growth-restricted fetuses","volume":"31","author":"El-Sayed","year":"2018","journal-title":"Menoufia Medical Journal"},{"key":"10.1002\/14651858.CD014498-BIB0040|cit40","unstructured":"STRIDER Ireland Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2014-003138-18-IE"},{"issue":"22","key":"10.1002\/14651858.CD014498-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1080\/14767058.2019.1690447","article-title":"Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial","volume":"34","author":"Furuhashi","year":"2021","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.preghy.2012.04.014","article-title":"Reduction of preeclampsia related complications with with the NO-donor penterythriltetranitrat (petn) in risk pregnancies - A prospective randomized double-blind placebo pilot study","volume":"2","author":"Groten","year":"2012","journal-title":"Pregnancy Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12884-019-2456-7","article-title":"Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial","volume":"19","author":"Groten","year":"2019","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.1002\/14651858.CD014498-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.placenta.2019.06.254","article-title":"Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN-Trial)","volume":"83","author":"Groten","year":"2019","journal-title":"Placenta"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.AOG.0000207637.01824.fe","article-title":"Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial","volume":"107","author":"Hladunewich","year":"2006","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014498-BIB0046|cit46","unstructured":"Effect of L-arginine versus placebo on intrauterine growth of the fetus in primigravid women https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20120215009014N419"},{"key":"10.1002\/14651858.CD014498-BIB0047|cit47","unstructured":"Effect of pentoxifiyllin on fetal growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20140317017034N9"},{"key":"10.1002\/14651858.CD014498-BIB0048|cit48","unstructured":"Prevention for Recurrence Of The preEClampsia with TAdalafil Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-jRCTs041180121"},{"issue":"10","key":"10.1002\/14651858.CD014498-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1055\/s-0031-1292696","article-title":"Reduction of intrauterine growth retardation (IUGR) in a high-risk group with the NO-donor penterythriltetranitrat (PETN) - A prospective randomized double-blind placebo trial","volume":"71","author":"Khachaturyan","year":"2011","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1469-0705.1998.12050334.x","article-title":"The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial","volume":"12","author":"Lees","year":"1998","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014498-BIB0051|cit51","unstructured":"Lopez-Molina K Gonzalez-Altamirano JC Valdivia-Silva JE Early L-arginine therapy improves notably the fetal growth in preeclamptic women. A randomized controlled trial 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 801"},{"key":"10.1002\/14651858.CD014498-BIB0052|cit52","unstructured":"Madhubala M Use of L. Arginine in oligohydramnios [abstract] 49th All India Congress of Obstetrics and Gynaecology; 2006 January 6-9; Cochin, Kerala State, India 2006 42"},{"key":"10.1002\/14651858.CD014498-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.23736\/S2724-606X.21.04827-2","article-title":"Effect of L-Arginine supplementation in pregnant women with chronic hypertension and previous placenta vascular disorders receiving aspirin prophylaxis: a randomized control trial","volume":"73","author":"Monari","year":"2021","journal-title":"Minerva Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014498-BIB0054|cit54","unstructured":"Impact of the NO-donor Pentaerythrithyltetrantrate on perinatal outcome in high-risk pregnancies Https:\/\/clinicaltrials.gov\/show\/NCT01355822"},{"key":"10.1002\/14651858.CD014498-BIB0055|cit55","unstructured":"Efficacy of sildenafil in preterm preeclampsia Https:\/\/clinicaltrials.gov\/show\/NCT02782559"},{"key":"10.1002\/14651858.CD014498-BIB0056|cit56","unstructured":"Evaluation of the efficacy of citrulline supplementation on the delay of delivery for women hospitalized for pre-eclampsia (CITRUPE) Https:\/\/clinicaltrials.gov\/show\/nct02801695"},{"key":"10.1002\/14651858.CD014498-BIB0057|cit57","unstructured":"Use of sildenafil citrate in management of mild pre-eclampsia Https:\/\/clinicaltrials.gov\/show\/nct03262961"},{"key":"10.1002\/14651858.CD014498-BIB0058|cit58","unstructured":"Pentaerithrityl Tetranitrate (PETN) for secondary prevention of intrauterine growth restriction Https:\/\/clinicaltrials.gov\/show\/nct03669185"},{"issue":"12","key":"10.1002\/14651858.CD014498-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3109\/14767051003677962","article-title":"L-arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications","volume":"23","author":"Neri","year":"2010","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0060|cit60","first-page":"212","article-title":"Nitric oxide in the prevention of pre-eclampsia","volume":"5","author":"Picciolo","year":"2000","journal-title":"Prenatal and Neonatal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD014498-BIB0061|cit61","first-page":"2617","article-title":"Prophylactic treatment for preeclampsia in high-risk teenage primigravidae with nitric oxide donors: a pilot study","volume":"29","author":"Razik","year":"2016","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"Pt 2","key":"10.1002\/14651858.CD014498-BIB0062|cit62","first-page":"486","article-title":"Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia [abstract]","volume":"29 Suppl 1","author":"Reyna-Villasmil","year":"2001","journal-title":"Journal of Perinatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.2005.01445.x","article-title":"Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia","volume":"35","author":"Rytlewski","year":"2005","journal-title":"European Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/10641955.2010.484083","article-title":"Phosphodiesterase inhibitor effect on small artery function in preeclampsia","volume":"30","author":"Samangaya","year":"2011","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD014498-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10641950802601278","article-title":"A randomised, double-blinded, placebo-controlled trial of the phosphodiesterase type 5 inhibitor sildenafil in the treatment of preeclampsia","volume":"28","author":"Samangaya","year":"2009","journal-title":"Hypertension in Pregnancy"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.preghy.2013.04.018","article-title":"Impact of the NO-donor pentaerythrithyltetranitrate on perinatal outcome in high-risk pregnancies: a prospective randomized double blinded pilot study","volume":"3","author":"Schlembach","year":"2013","journal-title":"Pregnancy Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD014498-BIB0067|cit67","first-page":"A.82","article-title":"Reduction of intrauterine growth retardation (IUGR) in a high-risk group with the no-donor penterythriltetranitrat (PETN) - a prospective randomized double-blind placebo trial","volume":"31","author":"Schleussner","year":"2010","journal-title":"Placenta"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0068|cit68","first-page":"641","article-title":"Erratum: Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: A prospective, randomized, double-blinded trial (Journal of Perinatal Medicine 42:4 (507-514) DOI: 10.1515\/jpm-2013-0212)","volume":"43","author":"Schleussner","year":"2015","journal-title":"Journal of Perinatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1515\/jpm-2013-0212","article-title":"Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial","volume":"42","author":"Schleussner","year":"2014","journal-title":"Journal of Perinatal Medicine"},{"issue":"83","key":"10.1002\/14651858.CD014498-BIB0070|cit70","first-page":"103","article-title":"Dietary supplementation with L-arginine or placebo in women with pre-eclampsia","volume":"83","author":"Staff","year":"2004","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD014498-BIB0071|cit71","first-page":"664","article-title":"Treatment of intrauterine growth retardation with magnesium sulfate","volume":"35","author":"Tan","journal-title":"Zhonghua Fu Chan Ke za Zhi"},{"key":"10.1002\/14651858.CD014498-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.placenta.2019.06.253","article-title":"PETN induced HO-1 expression in endothelial cells as a target for secondary prevention of endothelial dysfunction","volume":"83","author":"Teichert","year":"2019","journal-title":"Placenta"},{"key":"10.1002\/14651858.CD014498-BIB0073|cit73","unstructured":"Evaluation of blood pressure, blood flow fetal and neonatal outcome with the use of a phosphodiesterase type 5 inhibitor in the treatment of women with preeclampsia Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=RBR-8qj4p5"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial","volume":"128","author":"Trapani","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/AOG.0000000000001727","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial","volume":"128","author":"Vigil-De Gracia","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-5013(09)70342-5","article-title":"Effect of early L-arginine therapy on intrauterine growth restriction in preeclampsia. A randomized controlled trial in Latin-American women. [Spanish]","volume":"52","author":"Valdivia-Silva","year":"2009","journal-title":"Progresos en Obstetricia y Ginecologia"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/uog.2470","article-title":"Nitric oxide donors and fluid therapy increase fetal growth in gestational hypertension [abstract]","volume":"26","author":"Valensise","year":"2005","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijgo.2004.09.017","article-title":"L-arginine treatment for asymmetric fetal growth restriction","volume":"88","author":"Xiao","year":"2005","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD014498-BIB0079|cit79","unstructured":"Treatment of intra uterine growth retardation using vidaryadi ghrita and L-Arginne https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2019\/09\/021382"},{"key":"10.1002\/14651858.CD014498-BIB0080|cit80","unstructured":"Evaluate the effect of Madhumalinivasanta rasa along with Yastimadhuadi siddha ghrita matra basti in Upavistaka(intra-uterine growth restriction) compaire with L-arginine sachet https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2022\/03\/041053"},{"issue":"7","key":"10.1002\/14651858.CD014498-BIB0081|cit81","first-page":"632","article-title":"Sildenafil citrate and uteroplacental perfusion in fetal growth restriction","volume":"17","author":"Dastjerdi","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"issue":"8","key":"10.1002\/14651858.CD014498-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14767058.2017.1306509","article-title":"Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate","volume":"31","author":"El-Sayed","year":"2018","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD014498-BIB0083|cit83","unstructured":"Effect of Sildenafil citrate on uteri- placental perfusion, Doppler indices in growth restricted fetuses Https:\/\/clinicaltrials.gov\/show\/NCT02362399"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0084|cit84","first-page":"2989","article-title":"Sildenafil citrate and uteroplacental perfusion in fetal growth restriction","volume":"71","author":"El-Shalakany","year":"2018","journal-title":"Egyptian Journal of Hospital Medicine"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0085|cit85","first-page":"13643","article-title":"The effect of sildenafil on intrauterine growth restriction (IUGR) of fetus with gestational age above 28 weeks and neonatal outcomes","volume":"9","author":"Eshraghi","year":"2021","journal-title":"International Journal of Pediatrics"},{"key":"10.1002\/14651858.CD014498-BIB0086|cit86","unstructured":"The effect of sildenafil on intrauterine growth restriction (IUGR) of fetus with gestational age above 28 weeks and neonatal outcomes Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=TCTR20200526006"},{"issue":"7","key":"10.1002\/14651858.CD014498-BIB0087|cit87","first-page":"QC13","article-title":"Effect of transdermal nitroglycerine on doppler velocity waveforms of the uterine, umbilical and fetal middle cerebral arteries in patients with chronic placental insufficiency: a prospective RCT","volume":"11","author":"Gupta","year":"2017","journal-title":"Journal of Clinical and Diagnostic Research : JCDR"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014498-BIB0088|cit88","first-page":"131","article-title":"Effects of pentoxifylline and docosahexaenoic acid supplemental treatment in intrauterine growth restriction","volume":"27","author":"Huras","year":"2014","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.21608\/ejhm.2022.243004","article-title":"Difference between oral isosorbide mononitrate & sildenafil citrate therapy in reducing umbilical artery doppler indices in pregnancies with fetal growth restriction; a prospective randomized control trial","volume":"88","author":"Naseef","year":"2022","journal-title":"Egyptian Journal of Hospital Medicine"},{"key":"10.1002\/14651858.CD014498-BIB0090|cit90","unstructured":"Sildenafil and uteroplacental perfusion Https:\/\/clinicaltrials.gov\/show\/NCT01107782"},{"key":"10.1002\/14651858.CD014498-BIB0091|cit91","unstructured":"A trial evaluating the role of sildenafil in the treatment of fetal growth restriction Https:\/\/clinicaltrials.gov\/show\/NCT02590536"},{"key":"10.1002\/14651858.CD014498-BIB0092|cit92","unstructured":"Sildenafil citrate for the treatment of asymmetrical intrauterine growth restriction: a randomized controlled trial Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=PACTR201705002278236"},{"key":"10.1002\/14651858.CD014498-BIB0093|cit93","unstructured":"Sildenafil versus low molecular weight heparin in fetal growth restriction treatment https:\/\/clinicaltrials.gov\/show\/NCT03230162"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41372-019-0544-1","article-title":"Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial","volume":"40","author":"Rasheedy","year":"2019","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD014498-BIB0095|cit95","first-page":"283","article-title":"Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard)","volume":"184","author":"Serey","year":"1980","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD014498-BIB0096|cit96","unstructured":"Sildenafil in severe intrauterine growth retardation Https:\/\/clinicaltrials.gov\/show\/nct03153215"},{"issue":"10","key":"10.1002\/14651858.CD014498-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/14767058.2018.1523892","article-title":"Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial","volume":"33","author":"Shehata","year":"2018","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3109\/14767058.2010.531315","article-title":"Effect of L-arginine on the expression of Bcl-2 and Bax in the placenta of fetal growth restriction","volume":"24","author":"Shen","year":"2011","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12291-014-0450-4","article-title":"Effect of l-arginine on nitric oxide levels in intrauterine growth restriction and its correlation with fetal outcome","volume":"30","author":"Singh","year":"2015","journal-title":"Indian Journal of Clinical Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5005\/jp-journals-10006-1583","article-title":"A comparative study to assess the efficacy of sildenafil citrate and l-arginine in the management of fetal growth restriction","volume":"10","author":"Singh","year":"2018","journal-title":"Journal of SAFOG"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5005\/jp-journals-10006-1976","article-title":"Role of sildenafil citrate therapy in early-onset fetal growth restriction","volume":"13","author":"Yadav","year":"2021","journal-title":"Journal of SAFOG"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0102|cit102","first-page":"198","article-title":"Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension","volume":"27","author":"Zhang","journal-title":"Nan Fang Yi Ke da Xue Xue Bao [Journal of Southern Medical University]"},{"key":"10.1002\/14651858.CD014498-BIB0103|cit103","unstructured":"Sildenafil citrate with melatonin and intrauterine growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20160524028038N6"},{"key":"10.1002\/14651858.CD014498-BIB0104|cit104","unstructured":"Comparison of the effect of pomegranate juice with sildenafil in the treatment of intrauterine growth restriction https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20210730052014N1"},{"key":"10.1002\/14651858.CD014498-BIB0105|cit105","unstructured":"Treatment of restriction in fetal growth with L-arginine Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN32082979"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e054925","DOI":"10.1136\/bmjopen-2021-054925","article-title":"Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)","volume":"12","author":"Maki","year":"2022","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD014498-BIB0107|cit107","unstructured":"Tadalafil for fetus with early-onset growth restriction (TADAFER IIb) Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-jRCTs041190065"},{"key":"10.1002\/14651858.CD014498-BIB0108|cit108","unstructured":"L-Arginine in Pre-eclampsia Https:\/\/clinicaltrials.gov\/show\/nct00157521"},{"key":"10.1002\/14651858.CD014498-BIB0109|cit109","unstructured":"Sildenafil citrate for the management of asymmetrical intrauterine growth restriction Https:\/\/clinicaltrials.gov\/show\/NCT02678221"},{"key":"10.1002\/14651858.CD014498-BIB0110|cit110","unstructured":"Sildenafil citrate for treatment of growth-restricted fetuses Https:\/\/clinicaltrials.gov\/show\/nct03177824"},{"key":"10.1002\/14651858.CD014498-BIB0111|cit111","unstructured":"L-arginine in treatment of intrauterine growth restriction Https:\/\/clinicaltrials.gov\/show\/NCT03321292"},{"key":"10.1002\/14651858.CD014498-BIB0112|cit112","unstructured":"Arginine + citrulline as a supplement for weight gain in fetus with a decrease in their growth curve Https:\/\/clinicaltrials.gov\/show\/NCT05029778"},{"issue":"10","key":"10.1002\/14651858.CD014498-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"e020948","DOI":"10.1136\/bmjopen-2017-020948","article-title":"TADAFER II: tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial","volume":"8","author":"Umekawa","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD014498-BIB0114|cit114","unstructured":"A multicenter phase II trial of the efficacy and safety of tadalafil in fetus with early-onset growth restriction Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000023778"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012621.pub2","article-title":"Phosphodiesterase 5 inhibitors for pulmonary hypertension","author":"Barnes","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3945\/jn.115.221267","article-title":"L-Citrulline supplementation enhances fetal growth and protein synthesis in rats with intrauterine growth restriction","volume":"146","author":"Bourdon","year":"2016","journal-title":"Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/humupd\/4.1.25","article-title":"The nitric oxide pathway in pre-eclampsia: pathophysiological implications","volume":"4","author":"Buhimschi","year":"1998","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD014498-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trial in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.0000027813.55750.E7","article-title":"Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+\/hCAT-1 and y+\/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells","volume":"91","author":"Casanello","journal-title":"Circ ulation Research"},{"key":"10.1002\/14651858.CD014498-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12884-016-1009-6","article-title":"Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.1002\/14651858.CD014498-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/IJWH.S108370","article-title":"Sildenafil citrate for the management of fetal growth restriction and oligohydramnios","volume":"8","author":"Choudhary","year":"2016","journal-title":"International Journal of Women's Health"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/1471-0528.12172","article-title":"Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis","volume":"120","author":"Conde-Agudelo","year":"2013","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD014498-BIB0123|cit123","first-page":"632","article-title":"Sildenafil citrate and uteroplacental perfusion in fetal growth restriction","volume":"17","author":"Dastjerdi","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000453062","article-title":"Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes","volume":"41","author":"Dunn","year":"2017","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD014498-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14767058.2017.1306509","article-title":"Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate","volume":"31","author":"El-Sayed","year":"2018","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bcp.12379","article-title":"S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia","volume":"78","author":"Everett","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6 (Suppl 2)","key":"10.1002\/14651858.CD014498-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1693S","DOI":"10.1093\/jn\/137.6.1693S","article-title":"Adverse gastrointestinal effects of arginine and related amino acids","volume":"137","author":"Grimble","year":"2007","journal-title":"Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1471-0528.2003.02014.x","article-title":"A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation","volume":"110","author":"GRIT study group","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2S","key":"10.1002\/14651858.CD014498-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014498-BIB0131|cit131","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bcp.12301","article-title":"The nitric oxide pathway and possible therapeutic options in pre-eclampsia","volume":"78","author":"Johal","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/j.bbagen.2013.02.004","article-title":"S-Nitrosoglutathione","volume":"1830","author":"Broniowska","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"11","key":"10.1002\/14651858.CD014498-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.placenta.2011.06.025","article-title":"Role of nitric oxide in placental vascular development and function","volume":"32","author":"Krause","journal-title":"Placenta"},{"issue":"9","key":"10.1002\/14651858.CD014498-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14767050802220482","article-title":"Sildenafil administration to a patient with refractory persistent pulmonary hypertension of the newborn","volume":"21","author":"Latini","year":"2008","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/uog.11142","article-title":"Resolution of high uterine artery pulsatility index and notching following sildenafil citrate treatment in a growth-restricted pregnancy","volume":"40","author":"Lin","year":"2012","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00404-017-4341-9","article-title":"Fetal growth restriction: current knowledge","volume":"295","author":"Nardozza","year":"2017","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"11","key":"10.1002\/14651858.CD014498-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/14728222.2015.1088004","article-title":"Potential targets for the treatment of preeclampsia","volume":"19","author":"Oyston","year":"2015","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.117.09690","article-title":"Sildenafil during pregnancy: a preclinical meta-analysis on fetal growth and maternal blood pressure","volume":"70","author":"Paauw","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0141|cit141","first-page":"168","article-title":"Sildenafil citrate in fetal growth restriction","volume":"15","author":"Panda","year":"2014","journal-title":"Journal of Reproduction & Infertility"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bpobgyn.2004.02.003","article-title":"The role of uterine artery Doppler in predicting adverse pregnancy outcome","volume":"18","author":"Papageorghiou","year":"2004","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/GCO.0b013e32809bd964","article-title":"Uterine artery Doppler in the prediction of adverse pregnancy outcome","volume":"19","author":"Papageorghiou","year":"2007","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD014498-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000091352","article-title":"Sildenafil citrate and fetal outcome in pregnant rats","volume":"21","author":"Refuerzo","year":"2006","journal-title":"Fetal Diagnosis and Therapy"},{"key":"10.1002\/14651858.CD014498-BIB0145|cit145","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"4","key":"10.1002\/14651858.CD014498-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10641950802601278","article-title":"A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia","volume":"28","author":"Samangaya","year":"2009","journal-title":"Hypertension in Pregnancy"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"127 e1","DOI":"10.1016\/j.ajog.2007.06.068","article-title":"Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxia","volume":"198","author":"Sanchez-Aparicio","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3945\/jn.109.114678","article-title":"Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction","volume":"140","author":"Satterfield","year":"2010","journal-title":"Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000020969","article-title":"Intrauterine growth retardation and fetal cardiac function","volume":"15","author":"Severi","year":"2000","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2006.02.012","article-title":"Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline","volume":"132","author":"Smith","year":"2006","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.186270","article-title":"Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model","volume":"59","author":"Stanley","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD014498-BIB0152|cit152","first-page":"414","article-title":"[Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension]","volume":"49","author":"Sun","year":"2014","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"16","key":"10.1002\/14651858.CD014498-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1080\/14767058.2016.1229768","article-title":"Maternal citrulline supplementation enhances placental function and fetal growth in a rat model of IUGR: involvement of insulin-like growth factor 2 and angiogenic factors","volume":"30","author":"Tran","year":"2017","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014498-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial","volume":"128","author":"Goncalves","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.15673","article-title":"Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices","volume":"48","author":"Goncalves","year":"2016","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014498-BIB0156|cit156","article-title":"Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes","volume":"Online ahead of","author":"Turner","year":"2022","journal-title":"British Journal of Obstetrics & Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-0528.2010.02879.x","article-title":"Sildenafil citrate therapy for severe early-onset intrauterine growth restriction","volume":"118","author":"Dadelszen","year":"2011","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD014498-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/jc.2004-1831","article-title":"Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction","volume":"90","author":"Wareing","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD014498-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","article-title":"Amino acids: metabolism, functions, and nutrition","volume":"37","author":"Wu","year":"2009","journal-title":"Amino Acids"},{"key":"10.1002\/14651858.CD014498-BIB0160|cit160","unstructured":"Pels A Kenny L Baker P von Dadelszen P Gludd C Kariya C Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy PROSPERO 2020 CRD42020158093 Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020158093"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:02:45Z","timestamp":1760011365000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014498"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":160,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014498","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}